Kanada - angličtina - Health Canada

emd serono, a division of emd inc., canada - cetrorelix (cetrorelix acetate) - powder for solution - 0.25mg - cetrorelix (cetrorelix acetate) 0.25mg - gonadotropin-releasing hormone antagonists

Kanada - angličtina - Health Canada

emd serono, a division of emd inc., canada - cetrorelix (cetrorelix acetate) - powder for solution - 3mg - cetrorelix (cetrorelix acetate) 3mg - gonadotropin-releasing hormone antagonists

Austrálie - angličtina - Department of Health (Therapeutic Goods Administration)

merck healthcare pty ltd - cetrorelix, quantity: 0.25 mg - injection, powder for - excipient ingredients: mannitol - indications: prevention of premature luteinization and ovulation in patients undergoing a controlled ovarian stimulation, followed by oocyte pick up and assisted reproductive techniques. in clinical trials cetrotide was used with human menopausal gonadotrophin (hmg), however limited experience with recombinant fsh suggested similar efficacy.

Izrael - angličtina - Ministry of Health

merck serono ltd - cetrorelix as acetate - powder and solvent for solution for injection - cetrorelix as acetate 0.25 mg/vial - cetrorelix - prevention of premature ovulation in patients undergoing a controlled ovarian stimulation, followed by oocyte pick-up and assisted reproductive techniques.

Izrael - angličtina - Ministry of Health

merck serono ltd - cetrorelix as acetate - powder and solvent for solution for injection - cetrorelix as acetate 0.25 mg/vial - cetrorelix - prevention of premature ovulation in patients undergoing a controlled ovarian stimulation, followed by oocyte pick-up and assisted reproductive techniques.

Izrael - angličtina - Ministry of Health

merck serono ltd - cetrorelix as acetate - powder and solvent for solution for injection - cetrorelix as acetate 0.25 mg/vial - cetrorelix - prevention of premature ovulation in patients undergoing a controlled ovarian stimulation, followed by oocyte pick-up and assisted reproductive techniques.

Izrael - angličtina - Ministry of Health

merck serono ltd - cetrorelix as acetate - powder and solvent for solution for injection - cetrorelix as acetate 0.25 mg/vial - cetrorelix - prevention of premature ovulation in patients undergoing a controlled ovarian stimulation, followed by oocyte pick-up and assisted reproductive techniques.

Spojené státy - angličtina - NLM (National Library of Medicine)

meitheal pharmaceuticals inc. - cetrorelix acetate (unii: w9y8l7gp4c) (cetrorelix - unii:oon1hfz4ba) - cetrorelix acetate for injection is indicated for the inhibition of premature lh surges in women undergoing controlled ovarian stimulation. cetrorelix acetate is contraindicated under the following conditions: - hypersensitivity to cetrorelix acetate, extrinsic peptide hormones or mannitol. - known hypersensitivity to gnrh or any other gnrh analogs. - known or suspected pregnancy, and lactation (see precautions ). - severe renal impairment

Irsko - angličtina - HPRA (Health Products Regulatory Authority)

sun pharmaceutical industries europe b.v. - cetrorelix - solution for injection in pre-filled syringe - 0.25 milligram(s) - cetrorelix

Arménie - angličtina - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

baxter oncology gmbh - cetrorelix (cetrorelix acetate) - powder lyophilized for solution for s/c injection - 0,25mg